Genital Diseases, Female  >>  Actemra IV (tocilizumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Actemra IV (tocilizumab) / Roche, JW Pharma
PITCH, NCT01637532: Feasibility of the Combination of Chemotherapy (Carbo/Caelyx or Carbo/Doxorubicin) With Tocilizumab (mAb IL-6R) and Peg-Intron in Patients With Recurrent Ovarian Cancer

Completed
1/2
21
Europe
tocilizumab and interferon alpha 2-b, Carboplatin and Caelyx or doxorubicin
Leiden University Medical Center, University Medical Center Groningen
Recurrent Ovarian Cancer
09/13
09/13

Download Options